Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Jennifer Dotson to Inflammatory Bowel Diseases

This is a "connection" page, showing publications Jennifer Dotson has written about Inflammatory Bowel Diseases.

 
Connection Strength
  
 
 
9.771
  
  1. Farmer PF, Chen HF, Cooper J, Boyle B, Maltz RM, Michel HK, Dotson JL. Healthcare resource utilization and cost trends in pediatric inflammatory bowel disease within an accountable care organization. J Pediatr Gastroenterol Nutr. 2025 Oct; 81(4):1034-1044.
    View in: PubMed
    Score: 0.875
  2. Michel HK, Gorham TJ, Lee JA, Liu SB, Wright M, Maltz RM, Dotson JL. Impact of Telemedicine on Delivery of Pediatric Inflammatory Bowel Disease Care. J Pediatr Gastroenterol Nutr. 2023 10 01; 77(4):519-526.
    View in: PubMed
    Score: 0.763
  3. Gupta SR, Bricker J, Boyle BM, Maltz RM, Michel HK, Dotson JL. Outcomes for Standardized Home and Hospital-Based Infusions of Infliximab for Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2023 06 01; 76(6):776-781.
    View in: PubMed
    Score: 0.744
  4. Smith J, Jacobson-Kelly A, Donegan A, Boyle B, Maltz RM, Michel HK, Dotson JL. Diagnosis and Treatment of Iron Deficiency and Anemia in Youth With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2023 03 01; 76(3):313-318.
    View in: PubMed
    Score: 0.729
  5. Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis. 2022 09 01; 28(9):1420-1429.
    View in: PubMed
    Score: 0.717
  6. Pearlstein H, Bricker J, Michel HK, Afzali A, Donegan AM, Maltz RM, Boyle BM, Dotson JL. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 04 01; 72(4):563-568.
    View in: PubMed
    Score: 0.650
  7. Gupta SR, Crandall WV, Donegan A, Johnson M, Drobnic B, Oates M, Boyle B, Maltz RM, Dotson JL. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2019 11; 69(5):544-550.
    View in: PubMed
    Score: 0.589
  8. Dotson JL, Falaiye T, Bricker JB, Strople J, Rosh J. North American Pediatric Gastroenterology Fellowship Needs Assessment in Inflammatory Bowel Disease: Trainee and Program Director Perspectives. Inflamm Bowel Dis. 2016 07; 22(7):1616-20.
    View in: PubMed
    Score: 0.467
  9. Dotson JL, Kappelman MD. Overuse of the Emergency Department and CT Scans in Pediatric IBD: Time for Hot Spotting? J Pediatr Gastroenterol Nutr. 2015 Sep; 61(3):267-8.
    View in: PubMed
    Score: 0.441
  10. Dotson JL, Rosh JR. It is prudent to assess psychosocial functioning in children with inflammatory bowel disease. J Pediatr. 2015 May; 166(5):1108-9.
    View in: PubMed
    Score: 0.425
  11. Dotson J, Crandall W, Bout-Tabaku S. Exploring the differential diagnosis of joint complaints in pediatric patients with inflammatory bowel disease. Curr Gastroenterol Rep. 2011 Jun; 13(3):271-8.
    View in: PubMed
    Score: 0.329
  12. Dotson JL, Crandall W, Mousa H, Honegger JR, Denson L, Samson C, Cunningham D, Balint J, Dienhart M, Jaggi P, Carvalho R. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis. 2011 Jan; 17(1):56-61.
    View in: PubMed
    Score: 0.319
  13. Davidson N, Morris GA, Wright MA, Brock G, Boyle B, Dotson JL, Michel HK, Maltz RM. Predictors of antitumor necrosis factor primary nonresponse and drug durability in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2025 Oct; 81(4):1024-1033.
    View in: PubMed
    Score: 0.219
  14. Hinnant L, Rios Villacorta N, Chen E, Bacchus D, Dotson J, Greywoode R, Keefer L, Lupe S, Maggs L, Meek G, Szigethy E, Tomasino K, Ehrlich OG, Ehle S. Consensus Statement on Managing Anxiety and Depression in Individuals with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2025 May 12; 31(5):1248-1255.
    View in: PubMed
    Score: 0.216
  15. Wright JC, Ardura MI, Dotson JL, Boyle B, Maltz RM, Michel HK. Management and outcomes of histoplasmosis in youth with inflammatory bowel disease in an endemic area. J Pediatr Gastroenterol Nutr. 2024 Dec; 79(6):1153-1163.
    View in: PubMed
    Score: 0.207
  16. McLaughlin JF, Linville T, Jester TW, Marciano TA, Lazare F, Dotson JL, Samson C, Niklinska-Schirtz B, Cabrera J, Leibowtiz I, Batra S, Ammoury R, Strople JA, Saeed S, Sandberg KC, Tung J, Verstraete SG, Cox RF, Na S, Steiner SJ, Ali SA, Israel EJ, Dorsey J, Adler J, Rekhtman Y, Egberg MD, Waduge ER, Savas J, Brensinger CM, Lewis JD, Kappelman MD. Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2025 Apr; 23(5):825-834.
    View in: PubMed
    Score: 0.205
  17. David JG, Dotson JL, Mackner L. Multidisciplinary Perspectives on Medical Decision-Making for Ostomy Surgery in Pediatric IBD: Themes from Focus Groups. J Clin Psychol Med Settings. 2025 Jun; 32(2):278-285.
    View in: PubMed
    Score: 0.205
  18. McNicol M, Abdel-Rasoul M, McClinchie MG, Morris GA, Boyle B, Dotson JL, Michel HK, Maltz RM. Clinical outcomes and cost savings of a nonmedical switch to a biosimilar in children/young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 03; 78(3):644-652.
    View in: PubMed
    Score: 0.198
  19. Rowland P, McNicol M, Kiel A, Maltz RM, Donegan A, Dotson JL, Michel HK, Boyle B. Proactive therapeutic drug monitoring and vedolizumab dose optimization in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 Apr; 78(4):853-861.
    View in: PubMed
    Score: 0.197
  20. David JG, Michel HK, Dotson JL, Nwomeh BC, Boyle B, Donegan A, Maltz RM, McKillop HN, Mackner L. Psychosocial Considerations in Ostomy Surgery for Pediatric IBD Patients. J Wound Ostomy Continence Nurs. 2023 Mar-Apr 01; 50(2):104-106.
    View in: PubMed
    Score: 0.185
  21. Jain A, Bricker J, Kappelman MD, Dotson JL. Overweight and Obese Status Is Not Associated With Disease Activity for Children and Adolescents With Newly Diagnosed Inflammatory Bowel Disease. Am J Gastroenterol. 2022 07 01; 117(7):1146-1153.
    View in: PubMed
    Score: 0.175
  22. Yossef L, Wright M, Benedict J, Morris GA, McNicol M, Boyle B, Dotson JL, Michel HK, Maltz RM. Patient and Caregivers' Perspectives on Biosimilar Use in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2022 07 01; 75(1):59-63.
    View in: PubMed
    Score: 0.175
  23. Morris GA, McNicol M, Boyle B, Donegan A, Dotson J, Michel HK, Maltz RM. Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money. Inflamm Bowel Dis. 2022 03 30; 28(4):531-538.
    View in: PubMed
    Score: 0.174
  24. Guido AJ, Crandall W, Homan E, Dotson J, Maltz RM, Donegan A, Drobnic B, Oates M, Boyle B. Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2020 01; 70(1):48-54.
    View in: PubMed
    Score: 0.149
  25. Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 09; 67(3):341-345.
    View in: PubMed
    Score: 0.136
  26. Rieder F, Cohen BL, Dotson JL, Bewtra M, Ananthakrishnan AN, Falaiye TO, Ha CY. Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)-Promoting Improvement of Inflammatory Bowel Disease Education in the United States. Inflamm Bowel Dis. 2016 06; 22(6):1531-2.
    View in: PubMed
    Score: 0.116
  27. Donegan A, Boyle B, Crandall W, Dotson JL, Lemont C, Moon T, Kim SC. Connecting Families: A Pediatric IBD Center's Development and Implementation of a Volunteer Parent Mentor Program. Inflamm Bowel Dis. 2016 May; 22(5):1151-6.
    View in: PubMed
    Score: 0.115
  28. Iovino NA, McClinchie MG, Abdel-Rasoul M, Boyle B, Dotson JL, Michel HK, Maltz RM. Clinical impacts of immunomodulator withdrawal from anti-tumor necrosis factor combination therapy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 Oct; 79(4):885-894.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.